CLASS III Drug recall · Reported 7 May 2014 · FDA Enforcement Report

Papaverine 60 mg, Phentolamine 4 mg recalled by John W Hollis

John W Hollis is recalling Papaverine 60 mg, Phentolamine 4 mg, and Atropine 0.3 mg Solution Vial, distributed in Missouri, Mississippi, Tennessee, Wisconsin. The recall was initiated on 17 Mar 2014 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 1905, Expiry: 4/30/14
Quantity recalled1 vial

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1258-2014
FDA event ID
67812
Recalling firm
John W Hollis, Nashville, TN
Classification
Class III
Status
Terminated
Recall initiated
17 Mar 2014
FDA classified
25 Apr 2014
Reported
7 May 2014
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Other Reasons

Timeline

17 Mar 2014Recall initiated by company
25 Apr 2014Classified by FDA+39 days
7 May 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.

Product as listed by the FDA

Papaverine 60 mg, Phentolamine 4 mg, and Atropine 0.3 mg Solution, 10 mL Vial, Rx Only. Not for Resale. John Hollis Pharmacy, 110 20th Avenue N, Nashville, TN 37203.

Where it was distributed

MO, TN, MS, WI

MissouriMississippiTennesseeWisconsin

Questions about this recall

Why was it recalled?

Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.

Which lots are affected?

Lot #: 1905, Expiry: 4/30/14

Where was it sold?

MO, TN, MS, WI

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 67812

More recalls from John W Hollis

All 23

Other Papaverine recalls

All 64